Holders — by stockHoldings — by fund
Stonepine Capital Management, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001440771
$177.3M
disclosed book value
83
positions
7.2%
largest position share
Positions, as of 2026-06-30
top 87 of 83 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | VSTMVERASTEM INC | 3.3M | $12.8M | 7.2% |
| 2 | EOLSEVOLUS INC | 1.6M | $11.0M | 6.2% |
| 3 | TENXTENAX THERAPEUTICS INC | 660,000 | $9.6M | 5.4% |
| 4 | NKTRNEKTAR THERAPEUTICS | 120,654 | $8.4M | 4.8% |
| 5 | ADMAADMA BIOLOGICS INCCALL | 650,000 | $8.0M | 4.5% |
| 6 | ADMAADMA BIOLOGICS INC | 740,000 | $6.2M | 3.5% |
| 7 | CAMPCAMP4 THERAPEUTICS CORP | 1.4M | $6.1M | 3.4% |
| 8 | INSMINSMED INCCALL | 40,000 | $5.6M | 3.2% |
| 9 | ELOXELOXX PHARMACEUTICALS INC | 397,160 | $5.5M | 3.1% |
| 10 | RAREULTRAGENYX PHARMACEUTICAL INCALL | 200,000 | $5.5M | 3.1% |
| 11 | KZIAKAZIA THERAPEUTICS LTD | 345,179 | $4.9M | 2.7% |
| 12 | MDTMEDTRONIC PLCCALL | 50,000 | $4.4M | 2.5% |
| 13 | INDVINDIVIOR PHARMACEUTICALS INC | 100,000 | $4.1M | 2.3% |
| 14 | CRBPCORBUS PHARMACEUTICALS HLDGS | 425,000 | $4.0M | 2.2% |
| 15 | ABTABBOTT LABORATORIESCALL | 40,000 | $3.8M | 2.1% |
| 16 | MSLESATELLOS BIOSCIENCE INC | 491,624 | $3.7M | 2.1% |
| 17 | ZVRAZEVRA THERAPEUTICS INC | 258,701 | $3.7M | 2.1% |
| 18 | ABEOABEONA THERAPEUTICS INC | 557,284 | $3.4M | 1.9% |
| 19 | BSXBOSTON SCIENTIFIC CORPCALL | 50,000 | $3.3M | 1.8% |
| 20 | EDSAEDESA BIOTECH INC | 456,439 | $3.2M | 1.8% |
| 21 | EOLSEVOLUS INCCALL | 420,000 | $3.1M | 1.8% |
| 22 | BMRNBIOMARIN PHARMACEUTICAL INCCALL | 50,000 | $3.1M | 1.8% |
| 23 | CABACABALETTA BIO INC | 917,100 | $2.9M | 1.6% |
| 24 | ANTXAN2 THERAPEUTICS INC | 551,692 | $2.7M | 1.5% |
| 25 | XLOXILIO THERAPEUTICS INC | 225,994 | $2.2M | 1.2% |
| 26 | ACETADICET BIO INC | 245,518 | $2.1M | 1.2% |
| 27 | XERSXERIS BIOPHARMA HOLDINGS INCCALL | 280,000 | $2.1M | 1.2% |
| 28 | TELATELA BIO INC | 2.7M | $2.0M | 1.1% |
| 29 | AYTUAYTU BIOPHARMA INC | 912,921 | $2.0M | 1.1% |
| 30 | CRISEURCURIS INC | 3.3M | $1.7M | 1% |
| 31 | SPRBSPRUCE BIOSCIENCES INC | 28,795 | $1.6M | 0.9% |
| 32 | HRTXHERON THERAPEUTICS INCCALL | 1.0M | $1.5M | 0.8% |
| 33 | SIBNSI BONE INCCALL | 100,000 | $1.5M | 0.8% |
| 34 | OKYOOKYO PHARMA LTD | 862,996 | $1.3M | 0.7% |
| 35 | NMRANEUMORA THERAPEUTICS INC.CALL | 500,000 | $1.3M | 0.7% |
| 36 | KTTAPASITHEA THERAPEUTICS CORP | 2.2M | $1.1M | 0.6% |
| 37 | SLGLSOL-GEL TECHNOLOGIES LTD | 14,469 | $1.1M | 0.6% |
| 38 | LUNGPULMONX CORP | 815,436 | $1.1M | 0.6% |
| 39 | XFORX4 PHARMACEUTICALS INC | 224,989 | $1.1M | 0.6% |
| 40 | ARDXARDELYX INCCALL | 150,000 | $1.1M | 0.6% |
| 41 | DCTHDELCATH SYS INCCALL | 100,000 | $1.0M | 0.6% |
| 42 | INABIN8BIO INC | 695,287 | $980,355 | 0.6% |
| 43 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 50,000 | $973,500 | 0.5% |
| 44 | QNRXQUOIN PHARMACEUTICALS LTD | 199,486 | $965,512 | 0.5% |
| 45 | MXCTMAXCYTE INC | 751,606 | $924,475 | 0.5% |
| 46 | PHATPHATHOM PHARMACEUTICALS INC | 85,010 | $922,358 | 0.5% |
| 47 | AZTRAZITRA INC | 5.3M | $886,903 | 0.5% |
| 48 | CNTBCONNECT BIOPHARMA HLDGS LTD | 364,254 | $866,925 | 0.5% |
| 49 | HELPCYBIN INC | 129,280 | $854,541 | 0.5% |
| 50 | RAREULTRAGENYX PHARMACEUTICAL IN | 25,000 | $834,750 | 0.5% |
| 51 | IKTINHIBIKASE THERAPEUTICS INC | 396,179 | $804,243 | 0.5% |
| 52 | ZNTLZENTALIS PHARMACEUTICALS INC | 161,583 | $783,678 | 0.4% |
| 53 | CTMXCYTOMX THERAPEUTICS INC. | 205,000 | $768,750 | 0.4% |
| 54 | MNKDMANNKIND CORPCALL | 250,000 | $750,000 | 0.4% |
| 55 | NVCTNUVECTIS PHARMA INC | 40,000 | $735,600 | 0.4% |
| 56 | CBIOCRESCENT BIOPHARMA INC. | 40,000 | $720,000 | 0.4% |
| 57 | PMVPPMV PHARMACEUTICALS INC | 536,086 | $718,355 | 0.4% |
| 58 | ORKAORUKA THERAPEUTICS INC | 7,500 | $713,775 | 0.4% |
| 59 | RADXRADIOPHARM THERANOSTICS LTD | 51.0M | $670,500 | 0.4% |
| 60 | OKURONKURE THERAPEUTICS INC | 130,684 | $595,919 | 0.3% |
| 61 | NGENNERVGEN PHARMA CORP | 271,678 | $559,657 | 0.3% |
| 62 | CALCCALCIMEDICA INC | 622,432 | $544,939 | 0.3% |
| 63 | ARVNARVINAS INC | 60,000 | $498,600 | 0.3% |
| 64 | BIOABIOAGE LABS INC | 20,000 | $490,200 | 0.3% |
| 65 | IRDOPUS GENETICS INC | 100,718 | $413,951 | 0.2% |
| 66 | QTIQT IMAGING HLDGS INC | 100,000 | $407,000 | 0.2% |
| 67 | BOLDBOUNDLESS BIO INC | 154,595 | $386,488 | 0.2% |
| 68 | SINTSINTX TECHNOLOGIES INC | 209,205 | $332,531 | 0.2% |
| 69 | CLRBCELLECTAR BIOSCIENCES INC | 104,550 | $290,649 | 0.2% |
| 70 | EPRXEUPRAXIA PHARMACEUTICALS INC | 43,491 | $287,476 | 0.2% |
| 71 | SABSSAB BIOTHERAPEUTICS INC | 73,271 | $285,757 | 0.2% |
| 72 | ANLADLAI NORTYE LTD | 24,257 | $278,956 | 0.2% |
| 73 | SENSSENSEONICS HLDGS INC | 48,680 | $276,502 | 0.2% |
| 74 | PLRXPLIANT THERAPEUTICS INC | 230,538 | $262,813 | 0.1% |
| 75 | CDXSCODEXIS INC | 109,662 | $247,836 | 0.1% |
| 76 | POCIPRECISION OPTICS CORP INC MA | 46,390 | $236,589 | 0.1% |
| 77 | UPBUPSTREAM BIO INC | 33,432 | $231,349 | 0.1% |
| 78 | RNTXREIN THERAPEUTICS INC | 218,038 | $226,760 | 0.1% |
| 79 | HRTXHERON THERAPEUTICS INC | 490,787 | $209,468 | 0.1% |
| 80 | CNSPCNS PHARMACEUTICALS INC | 41,573 | $198,719 | 0.1% |
| 81 | HUMAHUMACYTE INC | 231,299 | $180,506 | 0.1% |
| 82 | KLRSKALARIS THERAPEUTICS INC | 30,122 | $122,597 | 0.1% |
| 83 | PCSAPROCESSA PHARMACEUTICALS INC | 55,000 | $105,600 | 0.1% |
| 84 | BCABBIOATLA INC | 16,432 | $68,028 | 0% |
| 85 | CGENCOMPUGEN LTD | 31,387 | $67,168 | 0% |
| 86 | OVIDOVID THERAPEUTICS INC | 21,300 | $57,297 | 0% |
| 87 | EVAXEVAXION AS | 17,562 | $54,442 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.